Company Description
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases.
Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
The company’s Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services.
Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research.
It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD.
Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
| Country | United States |
| Founded | 1956 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 125,000 |
| CEO | Marc Casper |
Contact Details
Address: 168 Third Avenue Waltham, Massachusetts 02451 United States | |
| Phone | 781 622 1000 |
| Website | thermofisher.com |
Stock Details
| Ticker Symbol | TMO |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000097745 |
| CUSIP Number | 883556102 |
| ISIN Number | US8835561023 |
| Employer ID | 04-2209186 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Marc N. Casper | Chairman, President and Chief Executive Officer |
| Stephen Williamson | Senior Vice President and Chief Financial Officer |
| Michel Lagarde | Executive Vice President and Chief Operating Officer |
| Frederick M. Lowery | Executive Vice President and President of Laboratory Product and BioProduction |
| Gianluca Pettiti | Executive Vice President and President of Life Science, Diagnostics and Applied |
| Joseph R. Holmes | Vice President and Chief Accounting Officer |
| Ryan J. Snyder | Senior Vice President and Chief Information Officer |
| Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer |
| Rafael Tejada | Vice President of Investor Relations |
| Thomas Bailey Shropshire Jr. | Senior Vice President and General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 23, 2025 | 8-K | Current Report |
| Jun 17, 2025 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| May 30, 2025 | SD | Form - SD |
| May 28, 2025 | 8-K | Current Report |
| May 22, 2025 | 8-K | Current Report |
| May 12, 2025 | 144 | Filing |
| May 2, 2025 | 10-Q | Quarterly Report |
| Apr 28, 2025 | 144 | Filing |
| Apr 23, 2025 | 8-K | Current Report |
| Apr 15, 2025 | UPLOAD | Filing |